Liwen Xi

1.7k total citations · 1 hit paper
13 papers, 1.3k citations indexed

About

Liwen Xi is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Epidemiology. According to data from OpenAlex, Liwen Xi has authored 13 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Epidemiology. Recurrent topics in Liwen Xi's work include Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Use and Resistance (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Liwen Xi is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (3 papers), Antibiotic Use and Resistance (2 papers) and Antibiotic Resistance in Bacteria (2 papers). Liwen Xi collaborates with scholars based in United States, Belgium and United Kingdom. Liwen Xi's co-authors include Ewa Wajs, Gary Meininger, Keith Usiskin, Dennis K. Yue, Elias David‐Neto, Bertrand Cariou, J.‐F. Yale, George L. Bakris, Wayne C. Drevets and Maggie Fedgchin and has published in prestigious journals such as Biological Psychiatry, Antimicrobial Agents and Chemotherapy and Psychopharmacology.

In The Last Decade

Liwen Xi

13 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

2013 418 citations J.‐F. Yale, George L. Bakris et al. Diabetes Obesity and Metabolism profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liwen Xi United States	11	626	416	266	239	232	13	1.3k
Nikolas Klein Austria	17	443 0.7×	74 0.2×	159 0.6×	52 0.2×	166 0.7×	21	1.2k
Britt‐Marie Eriksson Sweden	22	122 0.2×	93 0.2×	130 0.5×	45 0.2×	527 2.3×	58	1.7k
John H. Cavanaugh United States	23	222 0.4×	313 0.8×	201 0.8×	17 0.1×	173 0.7×	59	1.7k
Olivier Tribut France	19	296 0.5×	46 0.1×	73 0.3×	57 0.2×	416 1.8×	48	1.4k
Hee‐Sung Kim South Korea	15	152 0.2×	78 0.2×	106 0.4×	52 0.2×	137 0.6×	57	1.4k
Elisabet I. Nielsen Sweden	28	1.4k 2.2×	230 0.6×	173 0.7×	21 0.1×	597 2.6×	93	2.7k
Mehmet Köroğlu Türkiye	16	101 0.2×	46 0.1×	144 0.5×	344 1.4×	330 1.4×	132	1.6k
Timna Naftali Israel	22	679 1.1×	132 0.3×	355 1.3×	23 0.1×	249 1.1×	66	1.7k
Terry F. Plasse United States	15	677 1.1×	76 0.2×	175 0.7×	25 0.1×	129 0.6×	29	1.5k
Caterina Aurilio Italy	22	288 0.5×	104 0.3×	312 1.2×	10 0.0×	152 0.7×	95	1.7k

Countries citing papers authored by Liwen Xi

Since Specialization

Citations

This map shows the geographic impact of Liwen Xi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liwen Xi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liwen Xi more than expected).

Fields of papers citing papers by Liwen Xi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liwen Xi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liwen Xi. The network helps show where Liwen Xi may publish in the future.

Co-authorship network of co-authors of Liwen Xi

This figure shows the co-authorship network connecting the top 25 collaborators of Liwen Xi. A scholar is included among the top collaborators of Liwen Xi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liwen Xi. Liwen Xi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Timmers, Maarten, Paulien Ravenstijn, Liwen Xi, et al.. (2018). Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants. Journal of Psychopharmacology. 32(12). 1341–1350. 49 indexed citations

Morrison, Randall L., Maggie Fedgchin, Jaskaran Singh, et al.. (2018). Effect of intranasal esketamine on cognitive functioning in healthy participants: a randomized, double-blind, placebo-controlled study. Psychopharmacology. 235(4). 1107–1119. 57 indexed citations

Singh, Jaskaran, Maggie Fedgchin, Ella Daly, et al.. (2015). Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Biological Psychiatry. 80(6). 424–431. 320 indexed citations

Xi, Liwen, et al.. (2015). Comparing proton treatment plans of pediatric brain tumors in two pencil beam scanning nozzles with different spot sizes. Journal of Applied Clinical Medical Physics. 16(6). 41–50. 16 indexed citations

Prospero, Nicholas A. Di, Gahan Pandina, Lisa Ford, et al.. (2014). Evaluation of JNJ-26489112 in patients with photosensitive epilepsy: A placebo-controlled, exploratory study. Epilepsy Research. 108(4). 709–716. 7 indexed citations

Prospero, Nicholas A. Di, Patricia Andrade‐Gordon, Dana L. Johnson, et al.. (2014). CCR2 antagonism in patients with type 2 diabetes mellitus: a randomized, placebo‐controlled study. Diabetes Obesity and Metabolism. 16(11). 1055–1064. 31 indexed citations

Yale, J.‐F., George L. Bakris, Bertrand Cariou, et al.. (2013). Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes Obesity and Metabolism. 15(5). 463–473. 418 indexed citations breakdown →

Yale, Jean‐François, et al.. (2012). Canagliflozin (CANA), a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor, Improves Glycemia and is Well Tolerated in Type 2 Diabetes Mellitus (T2DM) Subjects With Moderate Renal Impairment. Canadian Journal of Diabetes. 36(5). S40–S41. 8 indexed citations

Fraser, Christophe, Joanne E. Tomassini, Liwen Xi, et al.. (2007). Modeling the long-term antibody response of a human papillomavirus (HPV) virus-like particle (VLP) type 16 prophylactic vaccine. Vaccine. 25(21). 4324–4333. 108 indexed citations

10.

Mistry, Goutam C., Anup Majumdar, Suzanne K. Swan, et al.. (2006). Pharmacokinetics of Ertapenem in Patients With Varying Degrees of Renal Insufficiency and in Patients on Hemodialysis. The Journal of Clinical Pharmacology. 46(10). 1128–1138. 35 indexed citations

11.

Stone, Julie A., Xin Xu, Gregory A. Winchell, et al.. (2004). Disposition of Caspofungin: Role of Distribution in Determining Pharmacokinetics in Plasma. Antimicrobial Agents and Chemotherapy. 48(3). 815–823. 111 indexed citations

12.

Musson, Donald G., Anup Majumdar, Steven M. Holland, et al.. (2004). Pharmacokinetics of Total and Unbound Ertapenem in Healthy Elderly Subjects. Antimicrobial Agents and Chemotherapy. 48(2). 521–524. 38 indexed citations

13.

Majumdar, Anup, Donald G. Musson, Steven M. Holland, et al.. (2002). Pharmacokinetics of Ertapenem in Healthy Young Volunteers. Antimicrobial Agents and Chemotherapy. 46(11). 3506–3511. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact